🔗 Share this article

Acclaimed soul vocalist D’Angelo passed away on October 14 at 51 years old after a personal fight with pancreatic malignancy.

“The brilliant light of our family has dimmed his light for us in the present world,” his relatives stated. “After a lengthy and brave struggle with cancer, we are heartbroken to declare that Michael D’Angelo Archer, known to his fans around the world as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on music with his pioneering modern soul style and partnerships with high-profile artists.

He launched his first record, “Brown Sugar,” in the mid-nineties to instant praise. The record achieved No. 4 on the R&B charts, went platinum later that year, and earned several Grammy nominations.

However, it was his second album, “Voodoo,” in 2000 that propelled his music career into the stratosphere. The record premiered at the top spot on each of the R&B charts and the Billboard 200. He won two Grammys: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a icon, albeit a hesitant one, in the cultural zeitgeist. The intimate portrayal featured the artist, famously bare to his waist, performing straight into the camera.

D’Angelo retreated from the spotlight after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was involved in a serious vehicle accident that put him in critical condition.

More than a decade later, his third and final album, “Black Messiah” (2014), confirmed his enduring appeal with a further No. 1 debut on the soul music rankings and a award for Top R&B Record.

Once more, in his own enigmatic fashion, D’Angelo had limited public outings in the subsequent period.

The singer was scheduled as a headliner for the 2025 Roots Picnic festival, but his performance was called off, due to an “unexpected health issue.”

Although details are sparse about D’Angelo’s well-being in the weeks leading up to his passing, he had apparently been hospitalized for an extended period and in hospice for two weeks.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic malignancy, one of the deadliest and hardest to prevent forms of the illness, on a gifted artist whose life was cut short.

“We are grieved that he can only provide dear memories with his family, but we are forever thankful for the legacy of deeply emotional music he leaves behind,” his family said.

Pancreatic Malignancy: Deadly and Difficult to Avoid

Pancreatic cancer impacts the pancreas, a tiny gland that produces the hormone insulin and plays an essential role in breaking down food, among other functions. The size and location of the pancreas in the human system make it more challenging to detect cancer.

Although pancreatic cancer makes up only about 3% of malignancy cases each year in the United States, it is causes 7% of cancer deaths.

Nearly seventy thousand individuals will be diagnosed with pancreatic cancer and roughly fifty-two thousand will die of the disease in the year 2025.

“Pancreatic cancer is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have limited and poor treatment options, and a smaller window to make a meaningful impact on the lives of people,” noted a cancer specialist.

Since pancreatic cancer seldom produces initial signs, it’s frequently diagnosed only after the disease is late-stage. Although a patient has indicators they are often nonspecific and may be confused with a number of everyday ailments.

“As of yet, there is no good way to detect pancreatic cancer in the initial phases, except for listening to your body and consulting your doctor if there are unfamiliar symptoms,” explained a medical director.

Frequent indicators of this disease encompass:

• abdominal or lower back pain
• weight loss
• jaundice
• reduced hunger
• brownish urine
• light-colored or greasy stools
• diarrhea
• increased appetite or thirst
• feeling sick

At age 51, D’Angelo’s death is an outlier, as pancreatic cancer is most common in individuals in the sixty-five to seventy-five range. However, many cancers, including this type, have become increasingly prevalent among younger people.

“Pancreatic cancer identified before the age of 50 is considered rare, yet concerningly, clinicians are noticing a rising count of younger patients affected by this disease,” said a expert.

Family History Affects Disease Probability

In the absence of reliable detection methods for pancreatic cancer, experts stressed the significance of understanding your family’s health background. Certain contributing elements, such as smoking and excess weight also play a role in the onset of pancreatic cancer.

African Americans have the greatest occurrence of this malignancy in the U.S. and are more prone to be found to have untreatable disease.

“The first step toward reducing one’s risk of pancreatic cancer is understanding personal risk factors. People should review their family history, genetic background, and medical conditions, such as blood sugar disease, chronic pancreatitis, or obesity that may raise their susceptibility,” said a medical professional.

Inherited genetic risk factors are linked to as much as 10% of all this malignancy instances. If someone in your family has had pancreatic cancer, you may want to consider DNA analysis.

“For people with a relative’s background of pancreatic cancer or those carrying high risk DNA changes, checking may involve advanced imaging such as magnetic resonance imaging (MRI) or internal ultrasound to detect initial alterations in the organ,” he clarified.

For those looking to lower their chance, habit adjustments may have an effect. The best step you can take to lower your risk of pancreatic cancer is to quit smoking, and if you don’t smoke, stay away altogether.

Heavy alcohol consumption is associated with pancreatitis, a risk factor for this malignancy, so limiting or abstaining from alcohol may assist reduce your risk.

Managing your body mass or losing weight may also help decrease your susceptibility. People with excess weight are 20% more likely to develop this disease. Pancreatic cancer also is more frequent in people with diabetes, and reducing weight can also reduce the chance of type 2 diabetes.

In spite of this disease’s poor prognosis, there is still hope.

“We are doing better with therapies and more recent combination chemotherapy. There are developing precision medicines that are already showing results,” remarked a specialist.

For many individuals, however, education about this rare but {dev